OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.

Saved in:
Bibliographic Details
Title: OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
Authors: Alhelaly M; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Ophthalmology Department, Tanta University, Tanta, Egypt., Soylu C; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Oncel D; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Corradetti G; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Chen K; Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California., Jackson NJ; Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California., Rathinam SR; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Gonzales JA; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California., Thundikandy R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Kanakath AV; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Coimbatore, India., Murugan SB; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Pondicherry, India., Vedhanayaki R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Lim LL; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia., Suhler EB; Casey Eye Institute, Oregon Health Science University, Portland, Oregon.; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon., Al-Dhibi HA; Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia., Doan T; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California., Sadda SR; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Madow B; Ira G. Ross Eye Institute, Department of Ophthalmology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/State University of New York (SUNY), Buffalo, New York., Coyne AB; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California., Acharya NR; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California., Tsui E; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Ocular Inflammatory Disease Center, UCLA Stein Eye Institute, Los Angeles, California.
Source: Ophthalmology science [Ophthalmol Sci] 2026 Feb 05; Vol. 6 (4), pp. 101106. Date of Electronic Publication: 2026 Feb 05 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 9918230896206676 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-9145 (Electronic) Linking ISSN: 26669145 NLM ISO Abbreviation: Ophthalmol Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-9145
DOI:10.1016/j.xops.2026.101106